EverSource Wealth Advisors’s Aura Biosciences AURA Stock Holding History

EverSource Wealth Advisors’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$980	Sell	138 -23	-14%	-$165	﹤0.01%	3968
2026 Q1	$1.08K	Sell	161 -127	-44%	-$729	﹤0.01%	3836
2025 Q4	$1.57K	Sell	288 -48	-14%	-$285	﹤0.01%	3582
2025 Q3	$2.08K	Buy	336 +28	+9%	+$183	﹤0.01%	3501
2025 Q2	$1.93K	Buy	308 +260	+542%	+$1.52K	﹤0.01%	3520
2025 Q1	$281	Buy	+48	New	+$363	﹤0.01%	3616

Other funds holding AURA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

nVerses Capital Wellington, Florida $65M AUM

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

EverSource Wealth Advisors's AURA Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Aura Biosciences (AURA) stake by 14% in Q2 2026, selling an estimated $165 and leaving 138 shares worth $980. The position accounts for ﹤0.01% of the portfolio, ranked #3968.

EverSource Wealth Advisors first reported a position in AURA in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.08K in Q3 2025. 26 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

EverSource Wealth Advisors held 138 shares of Aura Biosciences worth $980 as of Q2 2026.
EverSource Wealth Advisors sold 23 Aura Biosciences shares in Q2 2026, an estimated $165.
Aura Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3968 holding.
EverSource Wealth Advisors first reported a position in Aura Biosciences in Q1 2025 and has held it in 6 quarters since.
EverSource Wealth Advisors's Aura Biosciences position peaked at $2.08K in Q3 2025.
26 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.